Products

AiCure (H. Code)
AiCure
Drug Discovery & Research
AiCure's H.Code is an AI-powered platform using computer vision and predictive analytics to verify and improve medication and clinical behavior adherence in clinical trials and healthcare settings.

See all 1 product →

About AiCure

AiCure is a healthcare AI company that leverages artificial intelligence and advanced data analytics to enhance patient engagement and optimize clinical trials. Their core offering, the H.Code platform, utilizes AI-powered computer vision, synchronous chat, and predictive analytics to observe and assist trial participants remotely via their smartphones. This technology is designed to ensure medication adherence, capture objective behavioral data, and identify digital biomarkers that reflect treatment response and disease progression.

For physicians, AiCure’s platform provides critical insights into patient behavior outside of traditional clinical settings, addressing the significant challenge of poor adherence to therapy, which can lead to clinical trial failures and suboptimal patient outcomes. The system supports various study models, including site-based, decentralized, virtual, and hybrid trials, by offering real-time dosing instructions, electronic patient-reported outcomes (ePRO), and secure communication tools. By providing actionable, data-driven guidance and reducing the burden on clinical sites through its Site Services, AiCure aims to improve the predictability of study timelines, reduce costs, and accelerate drug development while enhancing the quality of patient care.

Focus Areas

AI-powered medication adherence patient engagement clinical trials digital biomarkers computer vision advanced data analytics drug development personalized medicine

Business Intelligence

Key InvestorsVive VC, New Leaf Venture Partners, Palisades Growth Capital, Singtel Innov8, Asahi Kasei Corporation, Accelmed Growth Partners, SpringRock Ventures, Baird Capital, Pritzker Group Venture Capital, Biomatics Capital, Tribeca Venture Partners, Silicon Valley Bank, National Institutes of Health (NIH)
PartnershipsOncoBay Clinical, Science 37, Defense Health Agency
AcquisitionsAcquired by Vive VC
TechnologyAI-native platform, computer vision, machine learning, advanced data analytics, mobile app (H.Code, Patient Connect), cloud-native (AWS-powered microservices architecture), digital biomarkers, predictive analytics, real-time monitoring, software-based (no custom hardware)
FDA Clearances1 (Class 1 exempt registration for multiple solutions: AiView®, AiView-SLTM, AiBreatheTM) cleared products (estimated)

What Physicians Need to Know

AI-Powered Medication Adherence
AiCure utilizes AI and computer vision to verify medication ingestion in real-time, ensuring patients take the right medication at the right time. Their mobile app provides reminders and easy-to-follow dosing instructions, significantly improving adherence rates in clinical trials and real-world settings.
Patient Engagement & Support
Through their H.Code and Patient Connect mobile applications, AiCure offers remote patient engagement tools including synchronous chat, video chat, and configurable ePRO capabilities. This approach reduces patient burden, enhances communication with care teams, and provides continuous support between clinic visits.
Clinical Trial Optimization
AiCure's platform is purpose-built for clinical trials, enhancing observation, adherence, and data quality. It improves predictability of study timelines, reduces costs, and accelerates drug development by providing real-time insights into patient behavior, leading to higher participant retention and improved statistical power.
Digital Biomarkers & Computer Vision
Leveraging computer vision and AI, AiCure captures visual and audio data via smartphones to detect subtle changes in patient conditions. This includes analyzing response time, affect, physical movement (e.g., facial tremors, eye twitches), and speech patterns, providing objective and sensitive measurements of disease state and treatment response.
Advanced Data Analytics
The platform aggregates and processes vast amounts of video, audio, image, and text data, offering real-time analytics, predictive insights, and customizable dashboards. This allows sponsors and clinical teams to monitor trial performance, patient dosing, symptoms, and intervention success rates to make data-driven decisions.
Drug Development & Personalized Medicine
By providing objective, real-world behavioral data and deeper insights into disease symptomology and treatment response, AiCure supports more informed drug development and advances the possibilities for precision medicine.
Physician Tip

For physicians, AiCure stands out by providing real-time, objective patient insights that go beyond traditional in-clinic visits. This means immediate visibility into medication adherence, symptom changes, and behavioral trends, enabling timely and targeted interventions. The AI-driven data collection reduces administrative burden on clinical staff, allowing them to focus more on patient relationships and complex care rather than manual data entry. By augmenting decision-making with predictive analytics and high-quality data, AiCure helps physicians identify at-risk patients sooner, improve patient engagement and retention, and ultimately enhance treatment outcomes and the validity of clinical trial data.

AiCure's platform is built with a microservices architecture and flexible APIs, allowing for seamless integration with existing clinical workflows, Electronic Health Records (EHRs)/Electronic Medical Records (EMRs), and Electronic Data Capture (EDC) systems. This ensures that their AI-powered insights can be incorporated into current healthcare IT infrastructures.

Products by AiCure

1 product in the directory

AiCure (H. Code)
AiCure
Drug Discovery & Research
AiCure's H.Code is an AI-powered platform using computer vision and predictive analytics to verify and improve medication and clinical behavior adherence in clinical trials and healthcare settings.

What the Web Says

AiCure is a company that utilizes AI and advanced data analytics, primarily focusing on an AI-powered adherence and dosing verification platform for clinical research and healthcare. While the product is praised for its advanced facial/computer-vision differentiation and ability to reduce dropout rates in trials, there are concerns about technical issues with the patient-facing app and a lack of extensive public reviews on major platforms like G2 and Capterra. As an employer, AiCure receives mixed to negative reviews, with employees citing issues with management, compensation, and job stability, despite appreciating the mission-driven culture and bright colleagues.

Overall: Mixed

Strengths

  • Advanced facial/computer-vision for detecting subtle behavioral signals.
  • Reported material dropout reductions in clinical trials when adherence monitoring and site support are used together.
  • Buyers value objective visual confirmation of dosing over self-report alone.
  • Mission-driven culture and collaborative colleagues.
  • Small and flexible company with great products.
  • Good work-life balance for some employees.

Limitations

  • Patient-facing app store reviews frequently mention technical issues with camera recognition, alarms, and support responsiveness.
  • Lack of extensive public reviews on G2 and Capterra makes peer comparison difficult.
  • Employees express dissatisfaction with management, compensation, and job security.
  • Frequent downsizing and lack of transparency.
  • Onboarding experience is described as negative, with the company being unprepared.
  • The pace of work is perceived as bureaucratic.

Based on reviews from: Comparably, Indeed.com, RFP.wiki, Apple App Store, Google Play Store

Last updated: 2026-08-14

Videos

News, demos, and interviews about AiCure.

Loading videos...

Videos load interactively. If none appear, search YouTube for AiCure →

View all on YouTube

Press & Coverage

Business Wire
AICure Expands Executive Leadership to Accelerate AI-Powered Medication Adherence, Remote Weight Verification, and Enterprise White-Label Solutions
AiCure announced the appointments of Anand Ramaswamy as Chief Product Officer and Olinka Greene as Director of Quality Assurance and Management to support the expansion of its AI-powered medication adherence platform, WeightVerify for remote weight verification, and enterprise white-label solutions.
2026-07
Forbes
Forbes: The AI Company Transforming Medication Adherence And Weight Loss
Forbes highlighted AiCure's AI and computer vision technology used on smartphones to remotely monitor patient adherence, providing verified data for clinical trials and chronic disease management. The company, recently acquired by Vive VC, holds over 85 patents and has launched WeightVerifyu2122 for remote weight monitoring.
2026-07
PR Newswire
AiCure Appoints Sabina Chadha as CEO, Ed Ikeguchi Transitions to Chief Medical Officer, and Josh Wilson Promoted to COO and President
AiCure announced Sabina Chadha as its new CEO, with former CEO Ed Ikeguchi transitioning to Chief Medical Officer, and Josh Wilson promoted to COO and President. These leadership changes aim to drive the company's clinical vision, innovation, and operational excellence.
2025-05
PR Newswire
AiCure Raises Funds, Secures New Patents, and Bolsters Leadership Team
AiCure completed a $12M loan refinancing and raised an additional $4M+ from existing investors, expanding its customer base and securing seven new US patents in 2023, bringing its total to 86.
2024-01
AiCure (American Pharmaceutical Review)
From Guidelines to Standards: Why Comprehensive AI Regulation is Essential to Spurring Innovation
Gordon Kessler, AiCure's General Counsel/Chief Administrative Officer, contributed an article to American Pharmaceutical Review discussing the essential role of comprehensive AI regulation in fostering innovation.
2023-10
PR Newswire
AiCure Launches Site Services to Reduce Burden and Optimize Research Operations for Clinical Sites
AiCure launched its clinical site services offering to provide customized support and monitoring of metrics related to adherence, compliance, data management, and technology use for study participants, aiming to minimize risk and optimize workflows for study coordinators.
2022-09
PR Newswire
AiCure Bolsters Global Presence and Team to Expand its Reach and Foster Diverse Perspectives
AiCure expanded its global presence through partnerships, a new employee base, and participation in key events, including a CRO partnership with Qwince and opening an international office in Nanjing, China.
2022-04
JMIR mHealth and uHealth (via PMC)
Use of a Novel Artificial Intelligence Platform on Mobile Devices to Assess Dosing Compliance in a Phase 2 Clinical Trial in Subjects With Schizophrenia
A pilot study evaluated AiCure's AI platform for measuring medication adherence in a Phase 2 trial for schizophrenia, demonstrating its potential to increase adherence and rapidly detect nonadherence compared to modified directly observed therapy.
2017-02

Frequently Asked Questions

AiCure utilizes an AI-powered smartphone application, such as H.Code or Patient Connect, to provide real-time dosing instructions and visually confirm medication ingestion through computer vision. This system alerts patients for doses, guides them through the process, and transmits adherence data to their care team, thereby improving compliance and engagement.
AiCure offers the H.Code patient engagement platform and the AiCure Platform, which leverage AI to monitor patient behavior, measure digital biomarkers, and verify medication adherence in clinical trials. These solutions aim to improve study timeline predictability, reduce costs, and accelerate drug development by providing objective data on treatment response and patient engagement.
AiCure employs computer vision and AI via a patient's smartphone camera to analyze visual and auditory cues, such as medication ingestion, facial expressions, speech patterns, and physical movements. These analyses capture digital biomarkers, offering objective and sensitive insights into treatment response and disease progression to enhance clinical trial data integrity.
AiCure maintains high standards for information security and data privacy, complying with HIPAA, GDPR, and 21 CFR Part 11 for protected health information (PHI). All data is encrypted at rest and in motion, with facial images securely stored on encrypted servers and access restricted to a small group of trained reviewers.
AiCure's platform supports integration with various data sources, patient companion apps, and existing clinical workflows to streamline operations. They provide AiCure Site Services, offering end-to-end customized support, individualized site training, and ad-hoc assistance to minimize the technological burden on clinical staff.
AiCure operates as a B2B2P company, primarily serving global pharmaceutical companies, contract research organizations (CROs), and healthcare providers. While specific pricing models are not publicly detailed, their solutions are offered as a platform to enhance patient engagement, medication adherence, and digital biomarker collection in clinical trials.
Founded in 2010, AiCure has raised over $55.8 million in funding across 10 rounds, including a Series C and additional funding in early 2024. They work with global clients in over 30 countries, including 7 of the top 10 global pharmaceutical companies, and have notable partnerships with organizations like Syneos Health and The IMA Group.

Investors

Who's funded AiCure.

Eurofarma Ventures
Corporate VC T2
Sao Paulo, Brazil
$1M-$5M
Eurofarma Ventures is the corporate venture arm of Eurofarma, one of Latin America’s largest pharmaceutical manufacturers, headquartered in Sao Paulo and deploying…
Biotech Digital Health
BlueRun Ventures Asia
VC T3
Hong Kong, Hong Kong
$1M-$5M
BlueRun Ventures Asia operates from Hong Kong as the Asian extension of the broader BlueRun Ventures platform, applying a long-running consumer and…
Consumer Health Digital Health
Mass General Brigham Ventures
Corporate VC T3
Somerville, United States
$1M-$5M
Mass General Brigham Ventures is a venture fund that creates and backs early-stage life sciences and digital health companies emerging from the…
Biotech Digital Health
TSVC
VC T3
Los Altos, United States
$250k-$1M
TSVC, based in Silicon Valley with a presence at tsvcap.com and an active Crunchbase profile, is an early-stage venture firm best known…
AI/ML in Healthcare Biotech
New Leaf Venture Partners
VC T3
New York, United States
unknown
New Leaf Venture Partners is a long-tenured US healthcare venture firm with a focus on later-stage biopharma and medical device investing, often…
Biotech Diagnostics
Moonfire Ventures
VC T3
London, United Kingdom
unknown
Moonfire Ventures is a London-based early-stage venture firm founded by Mattias Ljungman of Atomico fame, with a thesis built around using data…
AI/ML in Healthcare Digital Health
Flint Capital
VC T3
Boston, United States
$1M-$5M
Flint Capital is a Boston-based venture firm with a transatlantic thesis spanning the US, Europe, and Israel, focused on B2B software, fintech,…
AI/ML in Healthcare Digital Health

Related Companies

Google DeepMind is a leading artificial intelligence (AI) research laboratory, a subsidiary of Alphabet Inc., dedicated to developing advanced AI systems to benefit humanity. The company focuses on creating general-purpose AI that can learn and solve complex problems, drawing inspiration from neuroscience and machine learning. Their work spans various fields, including healthcare, scientific discovery, and […]

TalkToMedi is a Canadian healthcare AI company that has developed a clinical-grade voice AI platform called MEDI. This platform is designed to automate patient communication and administrative tasks for medical clinics, including family medicine, specialty clinics, allied health, and physiotherapy. MEDI handles high-volume patient calls, automating appointment inquiries, booking, rescheduling, and cancellations based on the […]

Menaela is an AI-first practice management system designed for solo practitioners, small private clinics, and clinic owners. It integrates patient communication, scheduling, CRM, and medical documentation into a single platform, aiming to replace multiple disconnected tools and bots. The system features an AI practice manager that understands natural-language requests, utilizes real clinic data, and performs […]

Avie is operated by AVIE TECNOLOGIA LTDA, headquartered in Santo André, São Paulo, Brazil. Avie provides WhatsApp reception in Brazilian Portuguese, appointment scheduling, rescheduling and cancellations through Google Calendar or Feegow, clinic CRM, follow-up messages and an online booking website. Clinic staff can review conversations and take over when human support is needed. Clinic CRM […]

Saile is a physician-founded healthcare technology company that addresses critical inefficiencies in healthcare staffing and credentialing. Their AI-powered platform acts as a “universal credential passport” for physicians, centralizing and managing all medical licenses, certifications, and CME credits in one secure, portable vault. This system aims to significantly reduce the administrative burden and delays associated with […]

Data Capture Experts (DCE) is an Australian-based healthcare AI company that is at the forefront of digital health transformation. They specialize in developing and implementing digital health platforms that integrate data, technology, and human-centered design to create intuitive and connected healthcare systems. Their flagship platform, DC2Vue, is designed to go beyond traditional Electronic Medical Records […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.